Identifying risk factors for toxicity in patients (Pts) with hormone-receptor positive (HR+) advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study Meeting Abstract
| Authors: | Li, D.; Dickler, M. N.; McCall, L. M.; Hahn, O. M.; Nudis, C. A.; Cohen, H. J.; Muss, H. B.; Ballman, K. V.; Winer, E. P.; Tripathy, D.; Schneider, B. P.; Cirrincione, C. T.; Barry, W. T.; Hurria, A. |
| Abstract Title: | Identifying risk factors for toxicity in patients (Pts) with hormone-receptor positive (HR+) advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 521s |
| Language: | English |
| ACCESSION: | WOS:000404712500035 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.10047 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10047 -- Source: Wos |
